This framework was applied to neural recordings from animals receiving one of the three anesthetics—propofol, ketamine, and dexmedetomidine.
When patients undergo general anesthesia, doctors can choose among several drugs. Although each of these drugs acts on ...
Several factors prevent the drug manufacturing industry from increasing supply to meet demand for scarce anesthetic drugs, which have been in a severe shortage for two years, according to a Med City ...
Propofol Shortage Overview and Current Availability Propofol injection is commonly used by ASCs and other healthcare providers because it is a quick acting sedative. Use of the drug has risen ...
Q: Considering that propofol is the most widely used anesthetic in our facility and that there are specific AAAHC expectations regarding the use of agents for which there are no reversal agents, ...
To help ease the propofol shortage, drug manufacturer Teva will be releasing product by the end of February, according to the American Society of Anesthesiologists. Teva discontinued propofol in 2010, ...
When patients undergo general anesthesia, doctors can choose among several drugs. Although each of these drugs acts on neurons in different ways, they ...
The drugmaker Teva said Friday that it will not make any more of its sedative propofol, a decision that could intensify a shortage of one of the most common anesthetics in the United States. The drug ...
Outcomes for mechanically ventilated adults with sepsis receiving light sedation were the same whether they received dexmedetomidine or propofol, according to data from a 13-center randomized, ...
When it comes to performing flexible fiberoptic bronchoscopy (FFB) on elderly patients, ensuring both comfort and safety is a ...
A medical expert looked jurors in the eyes Wednesday and told them that Michael Jackson's doctor committed 17 flagrant violations of the standard of care for his famous patient and was directly ...
DUBLIN--(BUSINESS WIRE)--The "United States Anesthesia Drugs Market by Type by General Inhalation by General Intravenous by Local, and Company Analysis 2025 to 2033" report has been added to ...